Article
09 Oct 2025
A Pivotal Week For Pharmaceutical Policy: Trump Administration Advances Tariff And Drug Pricing Initiatives
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
29 Sep 2025
Telehealth Update: We're Going To Need Congressional Approval
Article
19 Sep 2025
Mintz IRA Update — Disrupting The Pharmaceutical Supply Chain: The Era Of The DTC Model
Article
17 Sep 2025
Mintz IRA Update — IRA Medicare Drug Price Negotiation Program Updates For Q3 2025
Article
13 Jun 2025
PBM Policy And Legislative Update — Spring 2025 (Podcast)
Article
14 May 2025
CMS's 2026 Final Medicare Advantage Rule Focuses On Implementing The IRA And Deregulation
Article
26 Mar 2025
CMS's ACA Marketplace Integrity And Affordability Proposed Rule – What It Could Mean For Health Plans
Article
18 Feb 2025
Mintz IRA Update — The IRA In 2025: The Future Of Medicare Part D
Article
29 Aug 2024
California's Health Care Transactions Review Law: Regulatory Revisions Effective Immediately
Article
24 Jul 2024
The Consequences And Costs Of Redesigning The Part D Program
Article
18 Jul 2024
Opposition To The Use Of March-In Rights To Lower Drug Prices
Article
18 Jul 2024
Learning From Experience: Medicare Drug Price Negotiation Program Updates
Article
01 Apr 2024
A Mintz Health Care Roundtable: Current Trends In State Health Care Transaction Review And What To Expect In 2024
Article
04 Mar 2024
Mintz IRA Update — Biden Administration Proposes Allowing Agencies To 'March-In' To Control Rising Drug Prices
Article
04 Mar 2024
Mintz IRA Update — The IRA In 2024: The Medicare Drug Price Negotiation Program In Full Swing And Other Developments
Article
26 Oct 2023
Telehealth Update: DEA Extends Flexibility In Prescribing Controlled Substances Via Telehealth Through 2024
Article
10 Aug 2023
Transforming Primary Care: CMS Launches Making Care Primary (MCP) Model
Article
16 Jun 2023
The Supreme Court's SuperValu Decision On The "Knowingly" Element In The False Claims Act: Protecting Against Liability When There Is Regulatory Ambiguity
Article
06 Oct 2022
Recent Federal And State Legislative Action Targeting Health Care Staffing Agencies
Article
12 Aug 2022
Senate Democrats Pass Long-Awaited Drug Pricing Reforms In Budget Reconciliation Bill